SE452615B - Piperazinderivat och forfaranden for framstellning derav - Google Patents

Piperazinderivat och forfaranden for framstellning derav

Info

Publication number
SE452615B
SE452615B SE8100852A SE8100852A SE452615B SE 452615 B SE452615 B SE 452615B SE 8100852 A SE8100852 A SE 8100852A SE 8100852 A SE8100852 A SE 8100852A SE 452615 B SE452615 B SE 452615B
Authority
SE
Sweden
Prior art keywords
compound
piperazine
pharmaceutically acceptable
formula
fluorophenyl
Prior art date
Application number
SE8100852A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100852L (sv
Inventor
T Kanno
M Gaino
M Yamamura
R Ishida
K Shintomi
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SE8100852L publication Critical patent/SE8100852L/xx
Publication of SE452615B publication Critical patent/SE452615B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
SE8100852A 1980-02-18 1981-02-06 Piperazinderivat och forfaranden for framstellning derav SE452615B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1885580A JPS56115769A (en) 1980-02-18 1980-02-18 Piperazine derivative and its preparation

Publications (2)

Publication Number Publication Date
SE8100852L SE8100852L (sv) 1981-08-19
SE452615B true SE452615B (sv) 1987-12-07

Family

ID=11983145

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100852A SE452615B (sv) 1980-02-18 1981-02-06 Piperazinderivat och forfaranden for framstellning derav

Country Status (8)

Country Link
US (1) US4413006A (de)
EP (1) EP0034284B1 (de)
JP (1) JPS56115769A (de)
CA (1) CA1202973A (de)
DE (1) DE3161059D1 (de)
ES (1) ES8301952A1 (de)
IT (1) IT1136563B (de)
SE (1) SE452615B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58164583A (ja) * 1982-03-18 1983-09-29 Nippon Shinyaku Co Ltd フエノキシプロパノ−ルアミン誘導体
JPS6022136U (ja) * 1983-07-23 1985-02-15 株式会社　山見藤見鉄工所 豆刈り機
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
WO1997031910A1 (en) * 1996-02-28 1997-09-04 Merck & Co., Inc. Fibrinogen receptor antagonists
FR2761064B1 (fr) * 1997-03-20 1999-06-04 Pf Medicament Piperazines derivees d'amines cycliques, leur preparation et leur application comme medicaments
KR100342947B1 (ko) * 1997-04-30 2002-08-22 주식회사 엘지씨아이 제초활성 아릴피페라진아미드 유도체
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
TWI329102B (en) * 2006-08-15 2010-08-21 Nat Health Research Institutes Thiourea compounds and method for inhibiting hepatitis c virus infection
WO2008124300A1 (en) * 2007-04-10 2008-10-16 National Health Research Institutes Hepatitis c virus inhibitors
US7897764B2 (en) * 2007-06-08 2011-03-01 National Health Research Institutes Thiourea derivatives
US8198284B2 (en) * 2008-04-30 2012-06-12 National Health Research Institutes Treatment of neurodegenerative disorders with thiourea compounds
DE102013009248A1 (de) 2013-06-03 2014-12-04 MEYTON Elektronik GmbH Messrahmen zur berührungslosen optischen ermittlung einer durchschussposition und zugehöriges messverfahren
DE202013005777U1 (de) 2013-06-27 2013-07-10 MEYTON Elektronik GmbH Vorrichtung zum Wechseln eines Zielbildes und Messrahmen zur berührungslosen optischen Ermittlung einer Durchschussposition
DE202017101091U1 (de) 2017-02-27 2017-04-19 MEYTON Elektronik GmbH Messrahmen mit optischem Filter zur berührungslosen optischen Ermittlung einer Durchschussposition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB997166A (en) * 1961-07-14 1965-07-07 May & Baker Ltd N-phenylpiperazine derivatives
FR1535403A (fr) * 1962-12-26 1968-08-09 Abbott Lab Procédé de préparation d'éthers et de thio-éthers aromatiques de pipérazines n-substituées
GB1053301A (de) * 1963-01-14
US3764602A (en) * 1969-12-04 1973-10-09 Hoffmann La Roche 3-(4-phenyl-1 2, 6 di keto piperazinyl)-2-hydroxy-propoxy)-aniline
BE792187A (fr) * 1971-12-03 1973-03-30 Sumitomo Chemical Co Nouveaux derives d'alkylamines
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
JPS5840551B2 (ja) * 1976-08-06 1983-09-06 田辺製薬株式会社 プロパノ−ル誘導体及びその製法

Also Published As

Publication number Publication date
CA1202973A (en) 1986-04-08
US4413006A (en) 1983-11-01
JPS56115769A (en) 1981-09-11
ES499504A0 (es) 1983-01-01
IT8119814A0 (it) 1981-02-17
JPH0132222B2 (de) 1989-06-29
IT1136563B (it) 1986-09-03
EP0034284A2 (de) 1981-08-26
SE8100852L (sv) 1981-08-19
DE3161059D1 (en) 1983-11-10
ES8301952A1 (es) 1983-01-01
EP0034284B1 (de) 1983-10-05
EP0034284A3 (en) 1981-12-09

Similar Documents

Publication Publication Date Title
US4804658A (en) Imidazopyridine derivatives and pharmaceutical compositions
SE452615B (sv) Piperazinderivat och forfaranden for framstellning derav
US4994456A (en) Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
US20240166610A1 (en) Substituted pyridazine phenol derivatives
HUE029283T2 (en) 4- [2 - [[5-Methyl-1- (2-naphthalenyl) -1H-pyrazol-3-yl] oxy] ethyl] morpholine hydrochloride salt
CA3203447A1 (en) Series of piperidine-substituted benzoic acid compounds, and use thereof
EP4074699A1 (de) Verbindung als cyclin-abhängiger kinase-9-inhibitor und deren verwendung
US4619938A (en) Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
JPS6053014B2 (ja) 薬理作用を有するピリジン誘導体
CN116120296A (zh) 一种多环化合物、包含其的药物组合物、其制备方法及其用途
US4962200A (en) Nitrogen-containing compound
US5134151A (en) 2-picolylamine derivatives
EP0220653B1 (de) 3-Aminocarbonyl-1,4-dihydropyridin-5-carboxylsäurederivate, Verfahren zu ihrer Herstellung, ihre Verwendung und diese enthaltende pharmazeutische Zusammensetzungen
EP4206197A1 (de) Herstellungsverfahren für einen neuartigen rho-verwandten proteinkinasehemmer und zwischenprodukt in der herstellungsverfahren
US11760751B2 (en) Benzo 2-azaspiro[4.4]nonane compound and use thereof
AU2021328979A9 (en) Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof
JP7475370B2 (ja) ブルトン型チロシンキナーゼ阻害剤としての置換されている１－アミノ－１ｈ－イミダゾール－５－カルボキサミド
SK15572000A3 (sk) Spôsob prípravy enantiomérne čistého n-metyl-n-[(1s)-1-fenyl-2- -((3s)-s-hydroxypyrolidin-1-yl)etyl]-2,2-difenylacetamidu
CN117479934A (zh) 用于治疗肾纤维化的噁二唑基二氢吡喃并[2,3-b]吡啶的HIPK2抑制剂
HU180617B (en) Process for producing 1,2-bis-bracket-nicotinamido-bracket closed-propane,salts and pharmaceutical compositions containing them
JPH07300455A (ja) ３−フェニルピロリジン誘導体
EP0260605B1 (de) Dihydropyridin-5-phosphonsaure zyklische Ester
RU2819762C1 (ru) Соединение в качестве ингибитора циклинзависимой киназы 9 и его применение
JPH0733791A (ja) 新規燐脂質誘導体、該燐脂質の製造法、該燐脂質の精製法、腫瘍並びに原生生物の疾病および真菌類の疾病の撲滅および自己免疫疾患、皮膚疾患、骨髄の損傷およびウイルス性疾患の治療のための医薬並びに該医薬の製造法
DE19515500A1 (de) Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8100852-6

Effective date: 19940910

Format of ref document f/p: F